首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design
【24h】

Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design

机译:通过基于定点片段的虚拟药物设计发现Tyk2抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we synthesized compound 12 with potent Tyk2 inhibitory activity from FBDD study and carried out a cell- based assay for Tyk2/STAT3 signaling activation upon IFN alpha 5 stimulation. Compound 12 completely suppressed the IFN alpha 5-mediated Tyk2/STAT3 signaling pathway as well as the basal levels of pSTAT3. Stimulation with IFN alpha/beta leads to the tyrosine phosphorylation of the JAK1 and Tyk2 receptor-associated kinases with subsequent STATs activation, transmitting signals from the cell surface receptor to the nucleus. In conclusion, the potency of compound 12 to interrupt the signal transmission of Tyk2/STAT3 appeared to be equivalent or superior to that of the reference compound. (C) 2015 Elsevier Ltd. All rights reserved.
机译:在这项研究中,我们从FBDD研究中合成了具有有效Tyk2抑制活性的化合物12,并针对IFNα5刺激了Tyk2 / STAT3信号转导激活进行了基于细胞的测定。化合物12完全抑制IFNα5介导的Tyk2 / STAT3信号通路以及pSTAT3的基础水平。 IFNα/β刺激导致JAK1和Tyk2受体相关激酶的酪氨酸磷酸化,随后激活STAT,将信号从细胞表面受体传递至细胞核。总之,化合物12阻断Tyk2 / STAT3信号传输的能力似乎与参考化合物相同或更高。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号